Australia markets closed

TILT Holdings Inc. (TLLTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0250-0.0018 (-6.89%)
At close: 03:55PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.0269
Open0.0290
BidN/A x N/A
AskN/A x N/A
Day's range0.0223 - 0.0290
52-week range0.0150 - 0.0720
Volume363,851
Avg. volume242,411
Market cap8.368M
Beta (5Y monthly)1.55
PE ratio (TTM)N/A
EPS (TTM)-0.1900
Earnings date13 May 2024 - 17 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    TILT Holdings Crowned a NECANN Cup Winner Third Year in a Row

    Standard Farms Dubbed Best Vape Cartridge in MassachusettsPHOENIX, March 25, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (Cboe: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, announced today that its subsidiary Standard Farms won first place for best vape cartridge in the 2024 NECANN Cup with the Mimosa Liquid Live Rosin “All-in-One” Vape usin

  • GlobeNewswire

    TILT Holdings Reports Fourth Quarter and Full Year 2023 Results

    PHOENIX, March 14, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT" or the “Company”) (Cboe: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions that include inhalation technologies, cultivation, manufacturing, processing, brand development and retail, is reporting its financial and operating results for the three and twelve months ended December 31, 2023. All financial information is reported in U.S. dollars and prepared in accordance with U.S. generally accepted accountin

  • GlobeNewswire

    TILT Holdings Announces New Brand Partnership with LEVEL to Bring Their Cannabis Tablets to Pennsylvania

    Level’s Tablets to Launch in The Coming WeeksPHOENIX, March 13, 2024 (GLOBE NEWSWIRE) -- TILT Holdings Inc. (“TILT” or the “Company”) (NEO: TILT) (OTCQB: TLLTF), a global provider of cannabis business solutions including inhalation technologies, cultivation, manufacturing, processing, brand development and retail, today announced a new brand partnership to distribute LEVEL’s targeted, effects-based infused tablets to patients in Pennsylvania. “Partnering with LEVEL to bring their products to mar